Study number:
2007-00902-55
Type of transplant:
Short title:
RATGAA07
Study status:
Completed Patient Recruitment
Deadline for data collection:
Study design:
Non-randomized,prospective,multi-centre, phaseII pilot study
Primary objective:
Assess tolerability and efficacy of rabbit ATG (Thymoglobuline®) with CSA in the first line treatment of patients with acquired SAA, and patients with NSAA
Key inclusion criteria:
>=16years (18 in DE + CH)
Country:
France
Germany
Italy
Saudi Arabia
Switzerland
United Kingdom
Principal investigator:
Judith Marsh
Principal investigator email:
EBMT Study coordinator:
Alain Barrois